Yoon J - Search Results

1

Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study.

Oh DY, Lee KH, Lee DW, Yoon J, Kim TY, Bang JH, Nam AR, Oh KS, Kim JM, Lee Y, Guthrie V, McCoon P, Li W, Wu S, Zhang Q, Rebelatto MC, Kim JW. Oh DY, et al. Among authors: yoon j. Lancet Gastroenterol Hepatol. 2022 Jun;7(6):522-532. doi: 10.1016/S2468-1253(22)00043-7. Epub 2022 Mar 9. Lancet Gastroenterol Hepatol. 2022. PMID: 35278356 Clinical Trial.

2

Comparison of incidence of gastroesophageal reflux and regurgitation associated with timing of removal of the laryngeal mask airway: on appearance of signs of rejection versus after recovery of consciousness.

Cheong YP, Park SK, Son Y, Lee KC, Song YK, Yoon JS, Kim TY. Cheong YP, et al. Among authors: yoon js. J Clin Anesth. 1999 Dec;11(8):657-62. doi: 10.1016/s0952-8180(99)00117-8. J Clin Anesth. 1999. PMID: 10680108 Clinical Trial.

3

Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer.

Yoon J, Kang SY, Lee KH, Cheon GJ, Oh DY. Yoon J, et al. Cancer Res Treat. 2021 Apr;53(2):471-479. doi: 10.4143/crt.2020.577. Epub 2020 Oct 22. Cancer Res Treat. 2021. PMID: 33091966 Free PMC article.

4

Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy.

Yoo SH, Kang SY, Yoon J, Kim TY, Cheon GJ, Oh DY. Yoo SH, et al. Among authors: yoon j. Sci Rep. 2021 Jan 12;11(1):296. doi: 10.1038/s41598-020-78963-2. Sci Rep. 2021. PMID: 33436659 Free PMC article.

5

WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers.

Jin MH, Nam AR, Bang JH, Oh KS, Seo HR, Kim JM, Yoon J, Kim TY, Oh DY. Jin MH, et al. Among authors: yoon j. Gastric Cancer. 2021 Sep;24(5):1003-1020. doi: 10.1007/s10120-021-01176-7. Epub 2021 Mar 16. Gastric Cancer. 2021. PMID: 33723720

6

ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer.

Nam AR, Yoon J, Jin MH, Bang JH, Oh KS, Seo HR, Kim JM, Kim TY, Oh DY. Nam AR, et al. Among authors: yoon j. Cancer Lett. 2021 Sep 28;516:38-47. doi: 10.1016/j.canlet.2021.05.029. Epub 2021 May 31. Cancer Lett. 2021. PMID: 34082024 Clinical Trial.

7

Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer.

Seo HR, Nam AR, Bang JH, Oh KS, Kim JM, Yoon J, Kim TY, Oh DY. Seo HR, et al. Among authors: yoon j. Cancer Res Treat. 2022 Apr;54(2):541-553. doi: 10.4143/crt.2021.473. Epub 2021 Aug 6. Cancer Res Treat. 2022. PMID: 34352995 Free PMC article.

8

A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancers.

Oh KS, Nam AR, Bang JH, Seo HR, Kim JM, Yoon J, Kim TY, Oh DY. Oh KS, et al. Among authors: yoon j. Oncogene. 2022 Aug;41(32):3939-3952. doi: 10.1038/s41388-022-02384-w. Epub 2022 Jul 7. Oncogene. 2022. PMID: 35798878

9

Recent Progress in Immunotherapy for Gastric Cancer.

Yoon J, Kim TY, Oh DY. Yoon J, et al. J Gastric Cancer. 2023 Jan;23(1):207-223. doi: 10.5230/jgc.2023.23.e10. J Gastric Cancer. 2023. PMID: 36751000 Free PMC article. Review.

10

Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatment.

Kwon HJ, Park Y, Nam SK, Kang E, Kim KK, Jeong I, Kwak Y, Yoon J, Kim TY, Lee KW, Oh DY, Im SA, Kong SH, Park DJ, Lee HJ, Kim HH, Yang HK, Lee HS. Kwon HJ, et al. Among authors: yoon j. Cancer Med. 2023 May;12(9):10371-10384. doi: 10.1002/cam4.5769. Epub 2023 Mar 14. Cancer Med. 2023. PMID: 36916290 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,921 results

Search Page